RSV clinical trial tracker

This spreadsheet provides publicly available information on clinical trials of respiratory syncytial virus (RSV) candidate vaccines and monoclonal antibodies intended for prevention.

Sources of information for these trials are;;; and, which includes clinical trial registries from 17 countries.

Some information is also obtained through contact with investigators, sponsors, and funders of vaccine trials. This spreadsheet pairs with the RSV Vaccine and mAb Snapshot, which provides a summary of the RSV vaccine and mAb candidates in development worldwide.

Publication date: January 2024

RSV clinical trial tracker

211.4 KB XLSX
View Resource